Fmr LLC Kymera Therapeutics, Inc. Transaction History

Fmr LLC

$1.49 Trillion
Q1 2025

A detailed history of Fmr LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 4,409,234 shares of KYMR stock, worth $202 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,409,234

Previous 4,830,423 8.72%

Holding current value

$202 Million

Previous $194 Million 37.9%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$27.37 - $44.36 $11.5 Million - $18.7 Million	-421,189 Reduced 8.72%	4,409,234 $121 Million
Q4 2024 Feb 13, 2025	SELL	$39.06 - $51.84 $10.9 Million - $14.4 Million	-278,718 Reduced 5.46%	4,830,423 $194 Million
Q3 2024 Nov 13, 2024	BUY	$30.16 - $52.4 $8.51 Million - $14.8 Million	282,301 Added 5.85%	5,109,141 $242 Million
Q2 2024 Aug 13, 2024	BUY	$29.85 - $39.42 $13.8 Million - $18.2 Million	462,430 Added 10.6%	4,826,840 $144 Million
Q1 2024 May 13, 2024	BUY	$22.9 - $43.57 $87.7 Million - $167 Million	3,829,810 Added 716.39%	4,364,410 $175 Million
Q4 2023 Feb 13, 2024	SELL	$10.97 - $26.84 $3.69 Million - $9.02 Million	-335,947 Reduced 38.59%	534,600 $13.6 Million
Q3 2023 Nov 13, 2023	BUY	$13.9 - $23.88 $449,456 - $772,159	32,335 Added 3.86%	870,547 $12.1 Million
Q2 2023 Aug 11, 2023	BUY	$22.4 - $34.92 $3.83 Million - $5.97 Million	170,861 Added 25.6%	838,212 $19.3 Million
Q1 2023 May 11, 2023	SELL	$24.84 - $38.75 $4.44 Million - $6.92 Million	-178,695 Reduced 21.12%	667,351 $19.8 Million
Q4 2022 Feb 13, 2023	BUY	$19.57 - $30.92 $10.2 Million - $16.1 Million	520,360 Added 159.77%	846,046 $21.1 Million
Q3 2022 Nov 10, 2022	SELL	$20.91 - $34.27 $441,159 - $723,028	-21,098 Reduced 6.08%	325,686 $7.09 Million
Q2 2022 Aug 12, 2022	SELL	$14.13 - $42.55 $22.3 Million - $67.1 Million	-1,577,105 Reduced 81.97%	346,784 $6.83 Million
Q1 2022 May 13, 2022	SELL	$35.3 - $64.68 $15 Million - $27.4 Million	-423,638 Reduced 18.05%	1,923,889 $81.4 Million
Q4 2021 Feb 14, 2022	SELL	$49.91 - $65.56 $413,254 - $542,836	-8,280 Reduced 0.35%	2,347,527 $149 Million
Q3 2021 Nov 15, 2021	BUY	$47.8 - $66.66 $8.29 Million - $11.6 Million	173,378 Added 7.94%	2,355,807 $138 Million
Q2 2021 Aug 13, 2021	BUY	$31.08 - $51.95 $67.8 Million - $113 Million	2,182,429 New	2,182,429 $106 Million

Others Institutions Holding KYMR

# of Institutions

180

Shares Held

67.4M

Call Options Held

223K

Put Options Held

241K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.5B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account